G Production Inc
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Canada
- Registered address
- 19400 RTE Transcanadienne, Baie D'Urfe, QC H9X 3S4, Canada (CAN)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3003671557 · DUNS 251676961
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2023-02-17
- VAIDrug Quality Assurance2017-12-08
- NAIDrug Quality Assurance2015-02-13
- NAIDrug Quality Assurance2013-05-17
- NAIDrug Quality Assurance2011-09-29
- NAIDrug Quality Assurance2009-09-04
Drugs this plant is listed as making
13 distinct drugs across 19 products name this site in their FDA label.
- adapaleneGalderma Laboratories, L.P.
- adapalene and benzoyl peroxideMayne Pharma Inc.
- brimonidine tartrateGalderma Laboratories, L.P.
- calcitriolGalderma Laboratories, L.P.
- clobetasol propionateMayne Pharma Inc.
- desonideActavis Pharma, Inc.
- fluocinolone acetonide, hydroquinone, and tretinoinGalderma Laboratories, L.P.
- IvermectinGalderma Laboratories, L.P.
- Metronidazolein shortageMayne Pharma Inc.
- trifaroteneGalderma Laboratories, L.P.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.